| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Structural Biology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892
Human melanoma cell spreading on thrombospondin substrates and chemotaxis in a gradient of soluble thrombospondin requires the aminoterminal heparin/sulfatide-binding domain of thrombospondin. Some melanoma cell lines attach but do not spread or respond in chemotaxis assays. Sulfated glycoconjugates produced by melanoma cells that could mediate these activities were identified by metabolic labeling with [35S] sulfate and tested for their ability to bind thrombospondin. Heparan sulfate proteoglycans that bind thrombospondin are made by both spreading and non-spreading melanoma cell lines. Thrombospondin binds with high affinity to a high molecular weight heparan sulfate proteoglycan, but not to the major chondroitin sulfate. The active heparan sulfate proteoglycan can be partially purified by affinity chromatography on thrombospondin-agarose or hydrophobic interaction with octyl-Sepharose. Thrombospondin binding requires the amino-terminal domain and is inhibited by monoclonal antibody A2.5 or fucoidan. Binding activity is lost following degradation of the proteoglycan with heparatinase or nitrous acid. [35S]Sulfate labels several melanoma cell glycolipids including galactosylceramide-I3-sulfate, lactosyl ceramide-II3-sulfate, and sulfated glucuronosylparagloboside. The latter glycolipid was detected in three cell lines that spread on thrombospondin but not in the nonspreading C32 melanoma cells. Thrombospondin binds to the isolated glycolipid, and the glycolipid and an antibody to this structure inhibit cell spreading on thrombospondin substrates. Thus, the presence of glycoconjugates with terminal nonreducing glucuronosyl 3-sulfate correlates with melanoma cell spreading on thrombospondin, whereas expression of heparan sulfate proteoglycans that bind thrombospondin does not.
1 Address reprint requests to Building 10, Room 2A27, National Cancer Institute, NIH, Bethesda, MD 20892.
Received 5/13/88. Revised 8/19/88. Accepted 8/30/88.
This article has been cited by other articles:
|
|
 |
|
  Z. V. Popovic, R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al. Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity J. Immunol., November 15, 2007; 179(10): 6770 - 6782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. RUSNATI, G. TARABOLETTI, C. URBINATI, G. TULIPANO, R. GIULIANI, M. P. MOLINARI-TOSATTI, B. SENNINO, M. GIACCA, M. TYAGI, A. ALBINI, et al. Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat FASEB J, October 1, 2000; 14(13): 1917 - 1930. [Abstract] [Full Text]
|
|
|
|
 |
|
 N.-h. Guo, N. S. Templeton, H. Al-Barazi, J. Cashel, J. M. Sipes, H. C. Krutzsch, and D. D. Roberts Thrombospondin-1 Promotes {{alpha}}3{beta}1 Integrin-mediated Adhesion and Neurite-like Outgrowth and Inhibits Proliferation of Small Cell Lung Carcinoma Cells Cancer Res., January 1, 2000; 60(2): 457 - 466. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. M. Sipes, H. C. Krutzsch, J. Lawler, and D. D. Roberts Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and alpha vbeta 3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation J. Biol. Chem., August 6, 1999; 274(32): 22755 - 22762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Panetti, B. J. Kudryk, and D. F. Mosher Interaction of Recombinant Procollagen and Properdin Modules of Thrombospondin-1 with Heparin and Fibrinogen/Fibrin J. Biol. Chem., January 1, 1999; 274(1): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Greenwood, M. A. Pallero, A. B. Theibert, and J. E. Murphy-Ullrich Thrombospondin Signaling of Focal Adhesion Disassembly Requires Activation of Phosphoinositide 3-Kinase J. Biol. Chem., January 16, 1998; 273(3): 1755 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Utani, M. Nomizu, and Y. Yamada Fibulin-2 Binds to the Short Arms of Laminin-5 and Laminin-1 via Conserved Amino Acid Sequences J. Biol. Chem., January 31, 1997; 272(5): 2814 - 2820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, D. K. Strickland, and D. F. Mosher Metabolism of Thrombospondin 2. BINDING AND DEGRADATION BY 3T3 CELLS AND GLYCOSAMINOGLYCAN-VARIANT CHINESE HAMSTER OVARY CELLS J. Biol. Chem., July 5, 1996; 271(27): 15993 - 15999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Tsao and S. A. Mousa Thrombospondin Mediates Calcium Mobilization in Fibroblasts via Its Arg-Gly-Asp and Carboxyl-terminal Domains J. Biol. Chem., October 6, 1995; 270(40): 23747 - 23753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Sauk Stress Proteins in Development And Disease Critical Reviews in Oral Biology & Medicine, January 1, 1990; 1(4): 235 - 245. [Full Text] [PDF]
|
|
|
|
|
|
S. Goicoechea, A. W. Orr, M. A. Pallero, P. Eggleton, and J. E. Murphy-Ullrich Thrombospondin Mediates Focal Adhesion Disassembly through Interactions with Cell Surface Calreticulin J. Biol. Chem., November 10, 2000; 275(46): 36358 - 36368. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
